Kymera Therapeutics
KYMR
KYMR
252 hedge funds and large institutions have $6.99B invested in Kymera Therapeutics in 2025 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 97 increasing their positions, 64 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11.78% more ownership
Funds ownership: 113.1% → 124.88% (+12%)
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
41% less call options, than puts
Call options by funds: $9.18M | Put options by funds: $15.6M
Holders
252
Holding in Top 10
13
Calls
$9.18M
Puts
$15.6M
Top Buyers
| 1 | +$206M | |
| 2 | +$135M | |
| 3 | +$76M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$71.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$61M |
Top Sellers
| 1 | -$52.9M | |
| 2 | -$35.9M | |
| 3 | -$29.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$21.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$16.4M |
